Author: Pipper, Juergen; Inoue, Masafumi; Ng, Lisa F-P; Neuzil, Pavel; Zhang, Yi; Novak, Lukas
Title: Catching bird flu in a droplet Cord-id: 7lohh5ty Document date: 2007_9_23
ID: 7lohh5ty
Snippet: It is assumed that a timely mass administration of antiviral drugs, backed by quarantines and social distancing, could contain a nascent influenza epidemic at its source, provided that the first clusters of cases were localized within a short time. However, effective routine surveillance may be impossible in countries lacking basic public health resources. For a global containment strategy to be successful, low-cost, easy-to-use handheld units that permit decentralized testing would be vital. He
Document: It is assumed that a timely mass administration of antiviral drugs, backed by quarantines and social distancing, could contain a nascent influenza epidemic at its source, provided that the first clusters of cases were localized within a short time. However, effective routine surveillance may be impossible in countries lacking basic public health resources. For a global containment strategy to be successful, low-cost, easy-to-use handheld units that permit decentralized testing would be vital. Here we present a microfluidic platform that can detect the highly pathogenic avian influenza virus H5N1 in a throat swab sample by using magnetic forces to manipulate a free droplet containing superparamagnetic particles. In a sequential process, the viral RNA is isolated, purified, preconcentrated by 50,000% and subjected to ultrafast real-time RT-PCR. Compared to commercially available tests, the bioassay is equally sensitive and is 440% faster and 2,000–5,000% cheaper. SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nm1634) contains supplementary material, which is available to authorized users.
Search related documents:
Co phrase search for related documents, hyperlinks ordered by date